{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:29:58Z","timestamp":1777321798162,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autonomous AI systems in medicine promise improved outcomes but raise concerns about liability, regulation, and costs. With the advent of large-language models, which can understand and generate medical text, the urgency for addressing these concerns increases as they create opportunities for more sophisticated autonomous AI systems. This perspective explores the liability implications for physicians, hospitals, and creators of AI technology, as well as the evolving regulatory landscape and payment models. Physicians may be favored in malpractice cases if they follow rigorously validated AI recommendations. However, AI developers may face liability for failing to adhere to industry-standard best practices during development and implementation. The evolving regulatory landscape, led by the FDA, seeks to ensure transparency, evaluation, and real-world monitoring of AI systems, while payment models such as MPFS, NTAP, and commercial payers adapt to accommodate them. The widespread adoption of autonomous AI systems can potentially streamline workflows and allow doctors to concentrate on the human aspects of healthcare.<\/jats:p>","DOI":"10.1038\/s41746-023-00929-1","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T04:02:27Z","timestamp":1696564947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Autonomous AI systems in the face of liability, regulations and costs"],"prefix":"10.1038","volume":"6","author":[{"given":"Agustina D.","family":"Saenz","sequence":"first","affiliation":[]},{"given":"Zach","family":"Harned","sequence":"additional","affiliation":[]},{"given":"Oishi","family":"Banerjee","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3490-0037","authenticated-orcid":false,"given":"Michael D.","family":"Abr\u00e0moff","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8030-3727","authenticated-orcid":false,"given":"Pranav","family":"Rajpurkar","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"929_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41746-020-00324-0","volume":"3","author":"S Benjamens","year":"2020","unstructured":"Benjamens, S., Dhunnoo, P. & Mesk\u00f3, B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. npj Digit. Med. 3, 118 (2020).","journal-title":"npj Digit. Med."},{"key":"929_CR2","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2019.15064","volume":"322","author":"WN Price","year":"2019","unstructured":"Price, W. N., Gerke, S. & Cohen, I. G. Potential liability for physicians using artificial intelligence. Jama 322, 1765\u20131766 (2019).","journal-title":"Jama"},{"key":"929_CR3","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. \u201c11. Microvascular complications and foot care: standards of medical care in diabetes\u2212 2020.\u201d Diabetes care 43. Supplement 1: S135\u2013S151. https:\/\/diabetesjournals.org\/care\/article\/43\/Supplement_1\/S135\/30443\/11-Microvascular-Complications-and-Foot-Care (2020).","DOI":"10.2337\/dc20-S011"},{"key":"929_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2967\/jnumed.120.256032","volume":"62","author":"K Tobia","year":"2021","unstructured":"Tobia, K. et al. When Does Physician Use of AI Increase Liability? J. Nucl. Med. 62, 17\u201321 (2021).","journal-title":"J. Nucl. Med."},{"key":"929_CR5","unstructured":"Blueprint for Trustworthy AI Implementation Guidance and Assurance for healthcare Coalition for Health AI https:\/\/www.coalitionforhealthai.org\/papers\/blueprint-for-trustworthy-ai_V1.0.pdf."},{"key":"929_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-021-00549-7","volume":"5","author":"AAH de Hond","year":"2022","unstructured":"de Hond, A. A. H. et al. Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review. NPJ digital Med. 5, 2 (2022).","journal-title":"NPJ digital Med."},{"key":"929_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-021-01790-z","volume":"46","author":"E Crigger","year":"2022","unstructured":"Crigger, E. et al. Trustworthy augmented intelligence in health care. J. Med. Syst. 46, 12 (2022).","journal-title":"J. Med. Syst."},{"key":"929_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1001\/jamaoncol.2023.0012","volume":"9","author":"DS Bitterman","year":"2023","unstructured":"Bitterman, D. S., Kamal, A. & Mak, R. H. An Oncology Artificial Intelligence Fact Sheet for Cancer Clinicians. JAMA Oncol. 9, 612\u2013614 (2023).","journal-title":"JAMA Oncol."},{"key":"929_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00621-w","volume":"5","author":"MD Abr\u00e0moff","year":"2022","unstructured":"Abr\u00e0moff, M. D. et al. A reimbursement framework for artificial intelligence in healthcare. NPJ Digit. Med. 5, 72 (2022).","journal-title":"NPJ Digit. Med."},{"key":"929_CR10","unstructured":"New Medical Services ad New Technologies, Centers for Medicare and Medicaid Services https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/AcuteInpatientPPS\/newtech."},{"key":"929_CR11","doi-asserted-by":"publisher","unstructured":"Morey, J. R. et al. Impact of Viz LVO on time-to-treatment and clinical outcomes in large vessel occlusion stroke patients presenting to primary stroke centers. medRxiv 2020.07.02.20143834. https:\/\/doi.org\/10.1101\/2020.07.02.20143834 (2020).","DOI":"10.1101\/2020.07.02.20143834"},{"key":"929_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-018-0040-6","volume":"1","author":"MD Abr\u00e0moff","year":"2018","unstructured":"Abr\u00e0moff, M. D. et al. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit. Med. 1, 39 (2018).","journal-title":"NPJ Digit. Med."},{"key":"929_CR13","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/jama.2019.13978","volume":"322","author":"WH Shrank","year":"2019","unstructured":"Shrank, W. H., Rogstad, T. L. & Parekh, N. Waste in the US health care system: estimated costs and potential for savings. Jama 322, 1501\u20131509 (2019).","journal-title":"Jama"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00929-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:29:58Z","timestamp":1700476198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00929-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1038\/s41746-023-00929-1","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.D.A. is founder, director, and investor in Digital Diagnostics Inc. and is inventor on patents and patent applications related to this subject matter and assigned to the University of Iowa and Digital Diagnostics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}